F4 FundFund
TeamPortfolioRaiseEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesSimilar Firms
Hot Fund

Freiraum Ventures

freiraum.vc · Munich, Germany

Investment thesis

The next generation of great companies will be built on the technologies and ideas shaping our future. Backs knowledgeable, committed early-stage teams as first investor, with coaching and the SCE infrastructure.

$50K – $200K
Check Size
01Investment Thesis

The next generation of great companies will be built on the technologies and ideas shaping our future. Backs knowledgeable, committed early-stage teams as first investor, with coaching and the SCE infrastructure.

02Investment Team
DP
David Photien
Partner
KS
Klaus Sailer
Partner
HG
Herbert Gillig
Partner
DR
Daniel Rasel
Investment Associate
MK
Mateo Kulis
Visiting Analyst
03F4 Research Brief

Freiraum Ventures Research

Investment Thesis

Freiraum Ventures is an early-stage venture fund based in Munich, Germany. Its stated belief is that the next generation of great companies will be built on the technologies and ideas shaping our future. Knowledge and education are the first things it looks at in a team, followed by solid business ideas and strong, committed founders. It likes entrepreneurs who have already taken first steps and shown commitment, and it wants to be the first investor in the company.

Home and Backing

The fund's home is the Strascheg Center for Entrepreneurship (SCE), the entrepreneurship center of the Munich University of Applied Sciences. The fund is backed by Prof. Dr. Falk F. Strascheg, a founding partner of EXTOREL Private Equity Advisers and one of the most experienced venture capitalists in Germany and Europe. Beyond capital, portfolio founders get knowledge, coaching and access to the SCE infrastructure and network. Founders quoted on the site describe a transparent, fast investment process and support that continued after the round, including introductions and close communication.

Stage Focus

Freiraum invests in incorporated early-stage teams and startups, at pre-seed and seed. It is a sector-agnostic investor in practice, with a visible lean toward health and medical technology, biotech, software and deep tech (quantum software, space, climate hardware). It does not back pre-incorporation ideas; the team should be a company already.

Check Size

  • Ticket range: EUR 50k to EUR 200k
  • Average ticket: about EUR 100k
  • Average round size of its portfolio companies: about EUR 800k
  • Average entry valuation: about EUR 3.5M

Lead Tendency

Freiraum writes small first cheques and most of its rounds are syndicated. In its most recent public deal, RhymeQ's $2.2M pre-seed in October 2026, Ground State Ventures led and Freiraum took part alongside Vanagon Ventures and Plug and Play. Whether it leads rounds on its own is not stated.

Recent Activity

The firm lists 18 portfolio startups. Its most recent publicly announced investment is RhymeQ, a quantum software developer-tools startup, which announced a $2.2M pre-seed round on 22 October 2026. Freiraum does not publish the stage or date of its other investments. Its portfolio page also marks a few companies as having not worked out and one as liquidated.

Portfolio Highlights

Named portfolio companies include:

  • refinq
  • PANTOHealth
  • Voda
  • Xenopatch
  • INZIPIO Medical
  • Get2Germany
  • GetFit
  • breathment
  • ZEROTEC
  • ONYX Biotech
  • ARCSPACE
  • RhymeQ
  • Modelwise
  • Aponia
  • Oratis
  • PhysioFit

Two further companies are listed as stealth.

Team

  • David Photien, Partner
  • Prof. Dr. Klaus Sailer, Partner
  • Prof. Dr. Herbert Gillig, Partner
  • Daniel Rasel, Investment Associate
  • Mateo Kulis, Visiting Analyst

Decision Process

Freiraum decides as a partnership of three partners supported by an associate and an analyst. Founders apply through the application form on the website, and the fund says it actively invests. Warm introductions are not stated as required.

Founder Preferences

Founders with strong knowledge and education, often from universities and research (the partners have spoken about backing academic spin-offs), who have already incorporated and shown first traction or commitment. Founders who value hands-on help with go-to-market and growth rather than capital alone.

Geographic Focus

Munich and Germany first, with investments in companies built or expanding across Europe. Get2Germany and RhymeQ show it also backs teams with an international footprint.

How to Reach Them

Startups apply through the form on freiraum.vc or write to [email protected]. Investors can write to [email protected]. The office is at Hessstrasse 89, Munich.

04Selected Portfolio
Aerospace & Defense
ArcSpace
Biotech & Life Sciences
ONYX Biotech
Climate & Sustainability
refinq
Developer Tools & Infrastructure
RhymeQ
Enterprise Software
breathment·ZEROTEC
Healthcare & Digital Health
PhysioFit·Xenopatch·Voda·INZIPIO Medical·Get2Germany·GetFit·Aponia
Mobility & Transportation
PANTOHealth
Real Estate & PropTech
Oratis
Semiconductors & Hardware
Modelwise
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

Participated in RhymeQ's $2.2M pre-seed round led by Ground State Ventures.
INVESTMENT·businesswire.com
OCT 22, 2026
06Similar Firms
S
Singular
Up to $27M · Seed · Series A
→
KV
Kaya VC
$1M – $3M · Pre-Seed · Seed
→
FF
Founders Factory
Pre-Seed · Seed
→
BW
Blue Wire Capital
$350K – $1M · Pre-Seed · Seed
→
AE
Alpha Edison
$250K – $10M · Pre-Seed · Seed
→

Investor lists this firm appears in

  • Digital Health investors7 companiesPre-seed
  • Enterprise Software investors6 companiesPre-seed
Quick Reference
Check Size
$50K – $200K
Stages
Pre-Seed · Seed
Decision
Partnership
Involvement
Advisor
Location
Munich, Germany
Sector Focus
Biotech & Life SciencesEnterprise SoftwareHealthcare & Digital Health
Models
Early-Stage StartupsUniversity Spin-Offs
Technology
Health-TechMed-TechSoftware
See all Biotech & Life Sciences investors →See all Enterprise Software investors →See all Healthcare & Digital Health investors →
Visit freiraum.vc ↗

See how Freiraum Ventures matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Biotech & Life SciencesEnterprise SoftwareHealthcare & Digital Health

See how Freiraum Ventures matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched November 20, 2026F4 Research Engine